TIMOTHY FOLEY: Open Payments
NPI 1831147701 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,873 in 95 payments from 20 companies in 2025. Trend: 2023 $2,298 · 2024 $2,275 · 2025 $1,873
Food & beverage: $1,873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $355 |
| Novo Nordisk Inc | 13 | $276 |
| GlaxoSmithKline, LLC. | 12 | $235 |
| AstraZeneca Pharmaceuticals LP | 10 | $202 |
| PFIZER INC. | 10 | $168 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Lilly USA, LLC | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Exact Sciences Corporation | 3 | $69 |
| Axsome Therapeutics, Inc. | 3 | $60 |
Products named: QULIPTA, AIRSUPRA, Ozempic, TRELEGY ELLIPTA, SHINGRIX, REXULTI, NURTEC ODT, CAPLYTA.
Industry payments across NY — which companies pay providers there.
